These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27072378)

  • 1. Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders.
    Choi KY; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():134-47. PubMed ID: 27072378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of psychiatric and psychotherapeutic interventions in children and adolescents with psychiatric disorders--a systematic evaluation of meta-analyses and reviews. Part I: Anxiety disorders and depressive disorders].
    Bachmann M; Bachmann C; Rief W; Mattejat F
    Z Kinder Jugendpsychiatr Psychother; 2008 Sep; 36(5):309-20. PubMed ID: 18791981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction. Part II. When patients don't respond: clinical strategies for managing refractory anxiety and depression.
    Nemiah JC
    J Clin Psychiatry; 1994 Feb; 55 Suppl():18-9. PubMed ID: 7915711
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrating psychotherapy and pharmacotherapy.
    Hyland JM
    Bull Menninger Clin; 1991; 55(2):205-15. PubMed ID: 1675140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Depression and anxiety].
    Kasper S; Pezawas L
    Wien Med Wochenschr; 1999; 149(18):494-502. PubMed ID: 10637953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Cognitive Behavioral Therapy for Anxiety and Depression Be Improved with Pharmacotherapy? A Meta-analysis.
    Tolin DF
    Psychiatr Clin North Am; 2017 Dec; 40(4):715-738. PubMed ID: 29080596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More than just a pill. How to include psychosocial approaches sin the treatment of anxiety & depressive disorders.
    Rosenberg A; Lenze EJ
    Mo Med; 2013; 110(6):517-23. PubMed ID: 24564005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized anxiety disorder: between now and DSM-V.
    Allgulander C
    Psychiatr Clin North Am; 2009 Sep; 32(3):611-28. PubMed ID: 19716993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments for generalized anxiety disorder.
    Struzik L; Vermani M; Coonerty-Femiano A; Katzman MA
    Expert Rev Neurother; 2004 Mar; 4(2):285-94. PubMed ID: 15853570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotherapeutic approaches to the treatment of anxiety and depressive disorders.
    Michels R
    J Clin Psychiatry; 1997; 58 Suppl 13():30-2. PubMed ID: 9402917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotherapeutic issues in long-term treatment of anxiety disorder patients.
    Shear MK
    Psychiatr Clin North Am; 1995 Dec; 18(4):885-94. PubMed ID: 8748387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging the gap: Lessons we have learnt from the merging of psychology and psychiatry for the optimisation of treatments for emotional disorders.
    Graham BM; Callaghan BL; Richardson R
    Behav Res Ther; 2014 Nov; 62():3-16. PubMed ID: 25115195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comorbidity of anxiety and depression.
    Rodney J; Prior N; Cooper B; Theodoros M; Browning J; Steinberg B; Evans L
    Aust N Z J Psychiatry; 1997 Oct; 31(5):700-3. PubMed ID: 9400876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness of concise cognitive behavioral therapy with or without pharmacotherapy for depressive and anxiety disorders; a pragmatic randomized controlled equivalence trial in clinical practice.
    Meuldijk D; Carlier IV; van Vliet IM; van Veen T; Wolterbeek R; van Hemert AM; Zitman FG
    Contemp Clin Trials; 2016 Mar; 47():131-8. PubMed ID: 26762883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel treatment approaches for refractory anxiety disorders.
    Pollack MH; Otto MW; Roy-Byrne PP; Coplan JD; Rothbaum BO; Simon NM; Gorman JM
    Depress Anxiety; 2008; 25(6):467-76. PubMed ID: 17437259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurostimulation therapies for treatment resistant depression: a focus on vagus nerve stimulation and deep brain stimulation.
    Rizvi SJ; Donovan M; Giacobbe P; Placenza F; Rotzinger S; Kennedy SH
    Int Rev Psychiatry; 2011 Oct; 23(5):424-36. PubMed ID: 22200132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of mixed anxiety and depression.
    Degruy F
    Am Fam Physician; 1994 Mar; 49(4):860-6. PubMed ID: 7906917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of nonmelancholic depression: when antidepressants fail, does psychotherapy work?
    Parker G; Graham R; Sheppard E
    Can J Psychiatry; 2014 Jul; 59(7):358-65. PubMed ID: 25004496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders.
    Brown C; Schulberg HC; Madonia MJ; Shear MK; Houck PR
    Am J Psychiatry; 1996 Oct; 153(10):1293-300. PubMed ID: 8831437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.